Stockscreener 앱 받기
3.64
1.89%
-0.07
시간 외 거래:
3.65
0.010
+0.27%
전일 마감가:
$3.71
열려 있는:
$3.72
하루 거래량:
2.11M
Relative Volume:
0.43
시가총액:
$1.32B
수익:
$2.59M
순이익/손실:
$-137.89M
주가수익비율:
-4.4938
EPS:
-0.81
순현금흐름:
$-69.76M
1주 성능:
-2.93%
1개월 성능:
-13.95%
6개월 성능:
+34.81%
1년 성능:
+161.87%
1일 변동 폭
$3.61
$3.74
1주일 범위
$3.60
$3.8453
52주 변동 폭
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
명칭
Ataibeckley Inc
전화
49 89 2153 9035
주소
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
ATAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.64 | 1.35B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Ataibeckley Inc 주식(ATAI)의 최신 뉴스
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive Investors
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
Small cap wrap: AtaiBeckley, MustGrow Biologics, Silver Range Resources... - Proactive Investors
Needham Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
AtaiBeckley outlines 2026 mental health treatment pipeline milestones - Investing.com
AtaiBeckley Inc Provides 2026 Outlook and Clinical Updates Ahead of J.P. Morgan Healthcare Conference - Quiver Quantitative
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - FinancialContent
AtaiBeckley issues 2026 outlook, flags multiple clinical milestones - Proactive financial news
Redomiciliation And Deregistration Move Could Be A Game Changer For AtaiBeckley (ATAI) - simplywall.st
Free float of AtaiBeckley Inc. – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Income Statement – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Cash Flow – FWB:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Financial Disclosures & Filings - TradingView — Track All Markets
AtaiBeckley Inc. Statistics – XETR:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Balance Sheet – FWB:B72 - TradingView — Track All Markets
Total operating expenses of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Cash per share of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
AtaiBeckley (ATAI) Valuation Check As US Redomiciliation Marks A New Phase - simplywall.st
AtaiBeckley Inc. Revenue Breakdown – XETR:B72 - TradingView — Track All Markets
Number of employees of AtaiBeckley Inc. – XETR:B72 - TradingView — Track All Markets
Gross profit of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
EBIT per share of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Enterprise value of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Basic earnings per share (basic EPS) of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – FWB:B72 - TradingView — Track All Markets
Inventory turnover of ATAIBECKLEY INC. O.N. – FWB:B72 - TradingView — Track All Markets
ATAIBECKLEY INC. O.N. Earnings and Revenue – FWB:B72 - TradingView — Track All Markets
Optimism flows from pot to psychedelics: Atai Beckley, Supernus stocks rise after analyst flags positive tailwinds from Trump’s marijuana order - MSN
Ataibeckley Inc (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):